Aptinyx Competitors and Similar CompaniesClear all
Aptinyx's competitors and similar companies include XBiotech and Kymera Therapeutics.
 Aptinyx Aptinyx is a clinical-stage biopharmaceutical company focused on the discovery and development of transformative therapies for challenging neurologic disorders. |  XBiotech XBiotech is a biosciences company dedicated to the discovery, development, and commercialization of therapeutic antibodies based on its True Human technology.
|  Kymera Therapeutics Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases. | |
Founding Date | Founding Date 2015 | Founding Date 2005 | Founding Date 2017 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Evanston, US HQ Evanston, US | Locations Austin, US HQ | Locations Watertown, US HQ Cambridge, US |
Employees | Employees 635% increase | Employees 8510% decrease | Employees 207 |
Valuation ($) | Valuation ($) 4.1 m | Valuation ($) 234.4 m | Valuation ($) 3.1 b |
Financial | |||
Net income | Net income ($64.8m) (FY, 2022) | Net income ($45.5m) (FY, 2025) | Net income ($311.4m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 135m | Total funding raised N/A | Total funding raised $ 197m |
For sources of this data, please see the company profile
View Company Profiles
XBiotech
HQ
Austin, US
Employees
85↓ 10% decrease
XBiotech is a biosciences company dedicated to the discovery, development, and commercialization of therapeutic antibodies based on its True Human technology.
View companyKymera Therapeutics
HQ
Watertown, US
Employees
207
Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.
View company